bioMérieux Bloodstream Infection Educational Seminar: Charlotte

Time is of the essence! Rapid, actionable diagnostic results are vital in the treatment of a patient. Join bioMérieux, Inc. to learn about the critical role the laboratory plays in this process and gain valuable insights from our featured speakers who will share their experiences working against the clock to make informed treatment decisions. Our thought-leaders will also discuss the factors which can have a significant impact on your Antimicrobial Stewardship Programs.

Professional Acknowledgment for Continuing Education® (P.A.C.E.®) credits will be offered. bioMérieux, Inc. is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

Schedule of Events

4:00 - 4:30 pm Registration and networking reception
4:30 - 8:00 pm Featured presentations including dinner

Speakers & Topics

Randy Turner
Director, Medical and Scientific Advisor, Medical Affairs at bioMérieux, Inc. in St. Louis, MO

Moderator

Allison R. McMullen, Ph.D., D(BMM)
Assistant Professor of Pathology at Augusta University in Augusta, GA; Medical Director of the Clinical Microbiology Lab at AU Medical Center

Blood Cultures: The Next Generation - How bioMérieux’s BACT/ALERT® VIRTUO® System Can Improve Lab Workflow and Antimicrobial Stewardship
Dr. McMullen will discuss new technologies, including RT-PCR and MALDI-TOF MS, that have been developed to decrease the time to identification and susceptibility results for blood cultures. The bioMérieux BACT/ALERT® VIRTUO® features new technology to automate blood cultures and lead to a shorter time to detection. These changes allow for improved laboratory workflow and can aid in Antimicrobial Stewardship Programs.

John Hurst, PharmD, BCPS-AQ ID
Senior Director, Antimicrobial Stewardship at bioMérieux, Inc. in Durham, NC

How Rapid Diagnostics Can Drive Antimicrobial Stewardship
This session will describe the real world experience and clinical impact of an antimicrobial stewardship monitoring program focused on positive blood cultures paired with several available advanced diagnostics. Strategies for clinician and staff education and avoidance of common misunderstandings with rapid diagnostics will be discussed.

Daniel J. Feinstein, MD, FACP
Director Critical Care Medicine, Cone Health; Director MSICU, Moses Cone Memorial Hospital in Greensboro, NC; Clinical Assistant Professor, UNC Medical School

Diagnosis & Management of Sepsis and the Role of Procalcitonin
Dr. Feinstein will identify the kinetics and utility of procalcitonin (PCT) in sepsis patients and discuss how PCT-guided antibiotic therapy can enhance patient care and improve antibiotic stewardship. Through case studies, he will also show the clinical benefits of PCT, including its use in antibiotic stewardship programs.

 

Allison R. McMullen, Ph.D, D(ABMM) is Assistant Professor of Pathology at Augusta University and Medical Director of the Clinical Microbiology Lab at AU Medical Center. Dr. McMullen received her bachelor’s degree from Tulane University. She received her doctoral degree studying the Molecular Epidemiology of West Nile virus from the University of Texas Medical Branch. She completed a postdoctoral fellowship in the Chronic Viral Diseases Branch at the Centers for Disease Control and Prevention (CDC). Dr. McMullen completed a second postdoctoral fellowship in Medical and Public Health Microbiology at Washington University in St. Louis in 2016. She joined the faculty at Augusta University in July 2016 and is a Diplomate of the American Board of Medical Microbiology. Dr. McMullen’s research interests are focused primarily on antimicrobial susceptibility testing and resistance and new technology for clinical microbiology.

John M. Hurst, PharmD, BCPS-AQ ID graduated in 2010 from the University of Oklahoma College of Pharmacy. He then spent the next year in Birmingham, Alabama completing the PGY-1 Pharmacy Practice Residency at UAB Hospital. From there he continued East to Charleston, South Carolina where he completed a PGY-2 Infectious Diseases Pharmacy Residency at the Medical University of South Carolina (MUSC), under the guidance of mentors Dr. John Bosso and Dr. Lisa Steed. MUSC hired Dr. Hurst as a Clinical Pharmacy Specialist of Infectious Diseases following his residency. For two and a half years Dr. Hurst transformed and expanded the Antimicrobial Stewardship Program (ASP) at MUSC. During his tenure, the ASP expanded with the addition of a second full time stewardship pharmacist, presented and published ASP research. In 2015, Dr. Hurst joined SSM Health’s St. Anthony Hospital in Oklahoma City where he started a new Antimicrobial Stewardship Program. In October 2016, Dr. Hurst was promoted to Director of Antibiotic Stewardship. In November 2016 The Oklahoma Hospital Association recognized Dr. Hurst with the Spirit of Improving Patient Safety Award for his work implementing a clinical bacteremia treatment pathway based on rapid multiplex PCR results. In 2018 Dr. Hurst joined bioMérieux as Senior Director of Antimicrobial Stewardship. Dr. Hurst’s research and publication focus is on antimicrobial stewardship and the integration of rapid diagnostics into antimicrobial stewardship programs.

Daniel J. Feinstein, MD, FACP is the Director Critical Care Medicine and the Director MSICU at Moses Cone Hospital. Dr. Feinstein is board certified in Critical Care Medicine and Internal Medicine with extensive research and principal investigator in a multitude of trials for sepsis, shock, antibiotic stewardship and novel antibiotics.

Pioneering Diagnostics